Familial Combined Hyperlipidemia - Clinical Features, Diagnosis, and Treatment

What Is Familial Combined Hyperlipidemia?

Familial combined hyperlipidemia (FCHL) is a common metabolic disorder that causes high levels of cholesterol and triglycerides in the blood. It is an inherited condition, meaning it is passed down through families. Doctors usually identify this disease when two or more family members show high blood fat levels during testing. In the general population, it is the most common inherited lipid disorder, affecting about 0.5 to 2 percent of people.

This condition is a major concern for heart health. It is often found in people who have coronary heart disease. Specifically, statistics show that it affects 10% of people with heart disease and 11.3% of people under age 60 who have survived a heart attack. Because it significantly increases the risk of early heart attacks and strokes, identifying it early is vital for long-term survival.

How Is the Metabolism of Lipoproteins Affected in Familial Combined Hyperlipidemia?

In a healthy body, the liver efficiently manages fats. However, in people with FCHL, the liver does not function normally. Instead, it overproduces certain proteins called apoB-100-containing lipoproteins, which include VLDL and LDL. This overproduction leads to a buildup of cholesterol and triglycerides in the bloodstream.

Very Low-Density Lipoproteins (VLDL)

Patients with this disorder often have very high levels of VLDL. While scientists are still studying the exact reason, some research suggests the body struggles to break down VLDL after a meal. Another factor is reduced activity of the enzyme lipoprotein lipase, which is supposed to help clear these fats from the blood.

Low-Density Lipoproteins (LDL)

LDL is often called "bad cholesterol." In FCHL, the body contains more small, dense LDL particles. These particles are particularly dangerous because they are more likely to undergo oxidative damage, which can lead to clogged arteries. Interestingly, even if a patient takes medicine to lower their lipid levels, the structural problems with these LDL particles often remain.

High-Density Lipoproteins (HDL)

HDL, or "good cholesterol," helps protect the heart. In many patients with FCHL, HDL levels are lower than normal. This reduction is likely due to hepatic lipase, which becomes more active in these patients. The combination of high "bad" fats and low "good" fats creates a dangerous environment for the cardiovascular system.

What Is the Genetics of Familial Combined Hyperlipidemia?

It was earlier believed that familial combined hyperlipidemia occurs due to a defect in a single gene. But this was not true. Current studies indicate that it is polygenic, meaning that multiple genes contribute to this disease.

Hence, it has a significant feature that more than two people in the family have different blood test results.

• Chromosome 1: A specific region on chromosome 1q21-q23 has been linked to this disease in various populations, including families in Finland. This same genetic area is also connected to type 1 diabetes, and the two conditions share several clinical features.

• The USF1 Gene: This gene acts like a control switch for other genes that manage fat and sugar metabolism. Variations in the USF1 gene explain why the disease runs in families but presents differently in each person.

• Other Key Genes: Mutations in the LPL gene, which helps clear fats, and the LDLR gene, which regulates LDL receptors, also contribute to elevated blood fat levels.

What Are the Clinical Features of Familial Combined Hyperlipidemia?

In the early stages, a doctor's physical exam might appear completely normal. This makes the disease "silent" and easy to overlook. However, as the condition progresses, several symptoms may appear:

• Chest discomfort or pain.

• Shortness of breath or difficulty breathing.

• Leg pain while walking suggests circulation issues.

• Rarely, patients may develop xanthomas, which are visible cholesterol deposits in the skin.

A patient’s family history is the biggest clue. Doctors look for a history of high cholesterol, early heart disease, or relatives who died young from a stroke or heart attack. Additionally, external factors can make FCHL much worse, such as diabetes, obesity, hypothyroidism, and drinking too much alcohol.

How Is the Diagnosis of the Disease Made?

Diagnosing FCHL can be hard because the symptoms often look like metabolic syndrome. Because blood test results vary widely from one person to the next, the condition is often missed or not treated promptly.

To make a clear diagnosis, doctors use a lipid profile to check for:

1. High levels of LDL.

2. Low levels of HDL.

3. Increased triglycerides.

4. High levels of apolipoprotein B100.

Genetic testing can also be used to find the inheritance pattern within a specific family.

What Are the Treatment Strategies for Familial Combined Hyperlipidemia?

The main goal of treatment is to lower lipid levels and prevent a heart attack. Doctors typically use a two-part approach: lifestyle changes and medications.

Lifestyle Changes

This is the first and most important step in management. Patients are encouraged to:

• Eat a healthy diet that is very low in saturated and trans fats.

• Perform regular exercise to help the body process fats.

• Manage their weight effectively.

• Quit smoking and limit their intake of alcohol.

Medications

If lifestyle changes are not enough, several types of drugs can help:

• Statins: These are the most common drugs used to lower LDL and total cholesterol. They also help reduce triglycerides. Common examples include Atorvastatin and Rosuvastatin.

• Fibrates: These drugs, such as Fenofibrate, are used to lower triglycerides and help the body break down VLDL.

• Bile Acid Sequestrants: These medications bind to bile acids in the gut to help reduce LDL levels.

• PCSK9 Inhibitors: These are newer, powerful drugs used when statins do not lower LDL enough.

• Other Options: Doctors may also prescribe Niacin, Ezetimibe, or Omega-3 fatty acids, depending on the patient's specific needs.

Conclusion:

FCHL causes a constant rise in blood fats starting from a young age. Because the symptoms vary and can be invisible, many people do not know they have it until they experience a heart problem. Lifelong control of lipid levels is necessary to stay healthy. If you have a family history of heart disease or high cholesterol, it is important to talk to a general physician. Family screening is advised so that relatives can be tested and treated before serious complications like a stroke occur.

Key Takeaways:

1. Familial combined hyperlipidemia is a polygenic disorder characterized by high cholesterol and triglycerides.

2. Individuals with FCHL are at risk of premature coronary heart disease, stroke, and severe cardiovascular events.

3. It affects 10% of people with heart disease and 11.3% of people under age 60 who have survived a heart attack.